In sepsis patients, increasing glycolysis, promoting ATP production, and relieving lactic acidosis can significantly offset the immunosuppressive effects of LAC and enhance the immune function of the body (Liu et al., 2024), so may be possible to explore the treatment of severe COVID-19 patients through corresponding LAC blocking strategies, so as to improve their prognosis. The gene discussed is LCT; the disease is Sepsis.